![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 35, 24914-24920, August 27, 1999
§,
,
§,
§, and
From the
Manitoba Institute of Cell Biology,
University of Manitoba, Winnipeg, Manitoba, R3E 0V9 Canada, the
§ Department of Biochemistry and Molecular Biology,
University of Manitoba, Winnipeg, Manitoba, R3E 0W3 Canada, the
** Department of Biochemistry and Molecular Genetics, University of
Virginia, Charlottesville, Virginia 22908, and the
¶ Department of Cell Biology and Anatomy, Faculty of Medicine,
University of Calgary, Calgary, Alberta, T2N 4N1 Canada
| |
ABSTRACT |
|---|
|
|
|---|
When the Ras mitogen-activated protein kinase
(MAPK) signaling pathway of quiescent cells is stimulated with growth
factors or phorbol esters, the early response genes c-fos
and c-myc are rapidly induced, and concurrently there is a
rapid phosphorylation of histone H3. Using an antibody specific for
phosphorylated Ser-10 of H3, we show that Ser-10 of H3 is
phosphorylated, and we provide direct evidence that phosphorylated H3
is associated with c-fos and c-myc genes in
stimulated cells. H3 phosphorylation may contribute to proto-oncogene
induction by modulating chromatin structure and releasing blocks in
elongation. Previously we reported that persistent stimulation of the
Ras-MAPK signaling pathway in oncogene-transformed cells resulted in
increased amounts of phosphorylated histone H1. Here we show that
phosphorylated H3 is elevated in the oncogene-transformed mouse
fibroblasts. Further we show that induction of ras
expression results in a rapid increase in H3 phosphorylation. H3
phosphatase, identified as PP1, activities in
ras-transformed and parental fibroblast cells were similar,
suggesting that elevated H3 kinase activity was responsible for the
increased level of phosphorylated H3 in the oncogene-transformed cells.
Elevated levels of phosphorylated H1 and H3 may be responsible for the
less condensed chromatin structure and aberrant gene expression
observed in the oncogene-transformed cells.
Histone H1 and the N-terminal tail of H3 have key roles in the
folding and inter-association of the chromatin fiber (1-5). Modification of the N- and C-terminal tails of H1 by phosphorylation or
the N-terminal tail of H3 by acetylation and/or phosphorylation could
destabilize higher order chromatin structure (6, 7). Myc-
and ras-transformed and Rb-deficient fibroblasts have a more decondensed chromatin structure than parental cells (8-10). A general
feature of these oncogene-transformed and Rb-deficient cells is
increased H1 phosphorylation. H1 phosphorylation may relax chromatin by
interfering with its action in chromatin folding and intermolecular
fiber-fiber interactions (3).
Continuous stimulation of the Ras mitogen-activated protein kinase
(MAPK)1 signaling pathway in
mouse fibroblasts transformed with oncogenes ras,
fes, mos, and c-myc elevates the level
of phosphorylated H1 (9, 11). Activation of the Ras-MAPK signaling
pathway of quiescent fibroblasts treated with growth factors or phorbol esters results in the phosphorylation of H3 (12-14). Thus, persistent activation of the Ras-MAPK pathway in oncogene-transformed cells may
also increase the level of phosphorylated H3, contributing to the
destabilization of the higher order compaction of chromatin.
The N-terminal domain of H3 can be phosphorylated on Ser-10 and/or
Ser-28 (15, 16); however, the site of mitogen-induced phosphorylation
remains unknown. Phosphorylation of H3 happens concurrently with the
transcriptional activation of the immediate early response genes,
e.g. c-fos (12, 13). However, inhibition of
transcription does not prevent mitogen-activated H3 phosphorylation (12). It was proposed that phosphorylated H3 (pH3) is associated with
the immediate early genes and may be a prerequisite to the expression
of these genes (13). Unlike the extensive mitosis-specific phosphorylation, which occurs on all H3 molecules (17), this mitogen-stimulated phosphorylation is targeted to a small,
hyperacetylation-sensitive nucleosomal fraction (18).
To study H3 phosphorylation in growth factor- or phorbol
ester-stimulated quiescent and oncogene-transformed mouse fibroblasts, we used an antibody that specifically recognizes phospho-Ser-10 of H3.
We show that mitogenic stimulation, oncogene transformation, or
induction of oncogenic ras expression is accompanied with
increases in Ser-10 phosphorylation of H3. We provide direct evidence
that pH3 is associated with the induced c-fos and
c-myc genes in mitogen-stimulated fibroblasts. The elevated
levels of phosphorylated H3 in ras-transformed cells were
not a consequence of a decrease in the activity of PP1, which was
identified as the H3 phosphatase.
Cell Lines and Culture Conditions--
The cell line Ciras-3 was
derived from 10T1/2 cells by transfection with the T-24
Ha-ras oncogene (19). The NIH-3T3 mouse fibroblast
cell lines transformed with human c-myc,
v-mos, and v-fes were NIH/myc1, Mos 1, Fes 1, and
NIH/9IV#5, respectively (20). The 2H1 cell line was derived from
10T1/2 cells by transfection with the T-24 Ha-ras
oncogene under the control of a metallothionein promoter (21). Cell
lines were grown in plastic tissue culture plates in a humidified
atmosphere containing 7% CO2 in medium supplemented with
penicillin G (100 units/ml) and streptomycin sulfate (100 µg/ml).
Cell lines were grown in Manipulation of Cell Lines--
10T1/2 cells were grown
as described above and then serum starved in medium containing 0.5%
fetal bovine serum for 24 h. The cells were then either untreated
or treated with 50 ng/ml epidermal growth factor (EGF) or 100 nM TPA for 5 or 30 min. 2H1 cells (21) were grown as
described above, and then the medium was changed to fresh medium for
the control cells or medium containing 100 µM
ZnSO4 (to induce the ras oncogene) for 24 h.
After treatment, the medium was removed and the monolayer was washed
twice with phosphate-buffered saline, pH 7.3, and trypsinized. The
cells were collected by centrifugation and stored at Isolation of Histones--
For the isolation of histones,
approximately 4 × 107 to 1 × 108
cells were used. Cells were homogenized in 5 ml of nuclear preparation buffer (10 mM Tris-HCl, pH 7.6, 150 mM NaCl,
1.5 mM MgCl2, 0.65% Nonidet P-40, and 1 mM PMSF) in the presence of protein phosphatase inhibitors
(10 mM NaF, 1 mM sodium orthovanadate, 25 mM Fractionation of Chromatin--
Chromatin was fractionated by a
procedure described previously (22). Ciras-3 mouse fibroblasts
(1.35 × 108 cells) resuspended in RSB buffer were
homogenized several times and then passed through a syringe with a
22-gauge needle. Nuclei were collected by centrifugation. Nuclei were
resuspended in 5 ml of RSB buffer to 10 A260
units/ml. CaCl2 and micrococcal nuclease (Worthington
Biochemical Corporation) were added to 1 mM and 15 A260 units/ml, respectively. Digestion at
37 °C was for 7.5 min and then stopped by addition of EGTA to 10 mM. The nuclei were collected by centrifugation. The
supernatant, which did not contain chromatin fragments, was discarded.
The nuclei were sequentially incubated at 0 °C for 30 min with
buffer (50 mM Tris-HCl, pH 7.2, 2 mM
MgCl2, 25 mM KCl, 250 mM sucrose,
10 mM EDTA, 1% thiodiglycol, 1 mM PMSF, 25 mM Electrophoresis and Western Blotting--
Proteins were analyzed
by SDS-15% polyacrylamide gels. The proteins were visualized by
Coomassie Blue staining or transferred to nitrocellulose membranes (9).
The anti-pH3 was isolated as described (17). The membrane containing
the histones was immunochemically stained with anti-pH3 and horseradish
peroxidase-conjugated goat anti-rabbit antibody (Bio-Rad) using the ECL
(Enhanced Chemiluminescence) detection (Amersham Pharmacia Biotech).
The relative amount of pH3 in each sample was determined by scanning
the stained gel and the autoradiogram obtained from Western blots using
a PDI 325IE (PDI, Huntington Station, New York) and performing
densitometric analysis using the Imagemaster 1-D software (Amersham
Pharmacia Biotech, Uppsala, Sweden). The loading of each H3 sample was
corrected by dividing the value obtained for pH3 by the value obtained
for the amount of total H3 (from the Coomassie Blue stained gel). The
relative increase in pH3 in each of the preparations isolated from the
oncogene-transformed cell lines was divided by the value obtained for
the parental cell line as described previously (9).
To determine specificity of the antibody, total cellular protein from
Ciras-3 cells resolved on an SDS-15% polyacrylamide gel was
transferred to a membrane, which was subsequently immunochemically stained with anti-pH3 antibody. Only one band corresponding to pH3 was
detected on the immunoblot (results not shown). This result is in
agreement with previously published results (17). The anti-pH3 antibody
will detect pH3 in uncondensed and condensed (e.g.
centromeric heterochromatin) chromatin regions (17). Centromeric heterochromatin is associated with unacetylated histones.
Indirect Immunofluorescence Analysis--
Fixation and staining
of cells was carried out as described (17). In addition, cells were
co-stained with DAPI. Digital optical sectioning and deconvolution
microscopy of nuclei was performed as described (24).
CHIP Assays--
10T1/2 cells were serum starved and
either not treated or stimulated with TPA for 30 min. The cells were
then treated with 1% formaldehyde for 8 min (final concentration in
the medium) to cross-link histones to DNA. The cells were collected,
washed twice in phosphate-buffered saline, pH 7.4, and then washed for
10 min in solution 1 (0.25% (v/v) Triton X-100, 10 mM
EDTA, 0.5 mM EGTA, 10 mM HEPES, pH 7.5) and 10 min in solution 2 (0.2 M NaCl, 1 mM EDTA, 0.5 mM EGTA, 10 mM HEPES, pH 7.5). The pellet was
resuspended in lysis buffer (150 mM NaCl, 25 mM
Tris-Cl, pH 7.5, 5 mM EDTA, 1% Triton X-100, 0.1% SDS,
0.5% sodium deoxycholate) and sonicated for 4 min in 15-s bursts. DNA
fragments isolated from the lysate are referred to as input. Typically
90% of the nuclear DNA is present in the lysate. The lysate was
diluted 10-fold in lysis buffer, and anti-pH3 antibody was added and
incubated at 4 °C overnight. Immunoprecipitated complexes were
collected by adding protein A-Sepharose beads for 1 h at 4 °C.
Immunoprecipitates were washed once with RIPA (150 mM NaCl,
50 mM Tris-HCl, pH 8.0, 0.1% SDS, 0.5% sodium
deoxycholate, 1.0% Nonidet P-40), once in high salt wash (500 mM NaCl, 1.0% Nonidet P-40, 0.1% SDS, 50 mM Tris-Cl, pH 8.0), once in LiCl wash (250 mM LiCl, 1.0%
Nonidet P-40, 0.5% sodium deoxycholate, 1 mM EDTA, 50 mM Tris-Cl, pH 8.0) and twice in TE buffer (10 mM Tris-Cl, pH 8.0, 1 mM EDTA). The beads were
then treated with RNase (50 µg/ml) for 30 min at 37 °C and then
proteinase K overnight. The cross-links were reversed by heating the
sample at 65 °C for 6 h, and the DNA was extracted with
phenol/chloroform and was ethanol-precipitated. The DNA was then
labeled using the DIG DNA nonradioactive labeling system (Boehringer
Mannheim). The various genes of interest were slotted onto a nylon
membrane and probed with the immunoprecipitated or input labeled DNA.
Hybridizations were done at 68 °C overnight. The development times
ranged from 4 to 8 h. Note that the development times for blots
probed with immunoprecipitated DNA from nonstimulated and stimulated
cells were identical. The same protocol was applied for blots probed
with input DNA from nonstimulated and stimulated cells.
The four cloned DNA sequences used were immunoglobulin Phosphatase Assay--
A cell pellet containing 4 × 106 10T1/2 or Ciras-3 cells were lysed in Nonidet
P-40 buffer (10 mM Tris-HCl, pH 7.6, 150 mM
NaCl, 1.5 mM MgCl2, 0.65% Nonidet-P40, and 1 mM PMSF). The cellular extract was centrifuged at
10,000 × g for 10 min and the pellet discarded.
Okadaic acid was added (at a final concentration of either 2 nM or 100 nM) to 20 µg of cellular-extracted
protein in a 50-µl volume of Nonidet P-40 buffer. Five µg of total
histone (isolated by sulfuric acid extraction of 10T1/2 cells
that were treated with 0.06 µg/ml colcemid in media for 16 h)
was added. The reaction was allowed to proceed at 37 °C for 30 or 60 min. The reaction was stopped by the addition of SDS loading buffer. For the zero min time point, the reaction was immediately stopped by
the addition of SDS loading buffer. For comparison of phosphatase activity from 10T1/2 and Ciras-3 cell extracts, the extracts
were incubated with phosphorylated H3 for 15, 30, 45, and 60 min at 37 °C. The proteins were separated by SDS-polyacrylamide gel
electrophoresis, and Western blotting with the anti-pH3 antibody was
performed. To determine the level of phosphorylated H3 in each sample,
densitometric analysis of the Western blots was performed. The assays
were typically done in triplicate.
Induction of H3 Phosphorylation in Serum-starved 10T1/2
Cells in Response to Growth Factors and Phorbol Esters--
To
determine whether Ser-10 of H3 is phosphorylated in response to mitogen
stimulation, we used an antibody that was generated against Ser-10 pH3;
henceforth called anti-pH3 antibody. Serum-starved 10T1/2 cells
were treated with either EGF or TPA for 5 or 30 min, and the level of
pH3 was analyzed in immunoblotting experiments. We observed a
7.1-10.3-fold increase in the level of pH3 in the EGF- or TPA-treated
cells in comparison with the untreated 10T1/2 cells (Fig.
1). These results show that Ser-10 of H3
is phosphorylated in response to EGF or TPA stimulation.
Immunolocalization of pH3 in 10T1/2 Cells Treated with
TPA--
In murine cell lines, AT-rich centromeric heterochromatin can
be seen as regions of intense DAPI staining. These regions colocalize with the domains of intense H3 phosphorylation observed in
G2/M phase cells, reflecting G2 phosphorylation
of centromeric heterochromatin (17). In TPA-induced 10T1/2
cells, a second pattern is seen. The pH3 was located in numerous small
foci scattered throughout all interphase nuclei (Fig.
2, panel A). The pH3 foci
shown in Fig. 2 were found not to colocalize with centromeric
heterochromatin in three-dimension
reconstructions.2 In the vast
majority of the cells, all of the foci were located outside of
condensed regions of chromatin (Fig. 2, panel B). This observation is consistent with the hypothesis that pH3 of
mitogen-stimulated cells is associated with less condensed
chromatin.
Stimulated c-fos Gene Is Associated with pH3--
The CHIP
(chromatin immunoprecipitation) assay was used to test directly if pH3
was associated with immediate early genes, the expression of which is
stimulated in mitogen-stimulated cells (12, 29). Fig.
3 shows that pH3 of TPA-stimulated cells
was associated with c-fos and c-myc DNA sequences
(coding regions). In three separate experiments, the c-fos
DNA probe reproducibly gave a stronger signal than did the
c-myc DNA probe. Note, however, that both probes generated a
comparable signal when hybridized to the input DNA (from TPA-treated
cells). In contrast to expressed genes, transcriptionally inactive DNA
sequences (immunoglobulin Ras-transformed Fibroblasts Have Elevated Levels of pH3--
We
have shown previously that the levels of phosphorylated H1 were
elevated in ras-transformed mouse fibroblasts in which the
Ras-MAPK signaling pathway is persistently activated (9). In this
study, we investigated whether persistent activation of the Ras-MAPK
signaling pathway would elevate the steady state levels of pH3 in
ras-transformed Ciras-3 cells. In immunoblotting experiments
with anti-pH3 antibody, we observed that the level of pH3 was elevated
in Ciras-3 cells (Fig. 4B,
compare lane 2 with lane 1). As H3
phosphorylation at Ser-10 is high during mitosis (17), it was necessary
to compare the cell cycle distribution of the Ciras-3 and 10T1/2
cells. Using flow cytometric analysis of the cell populations, we found
that the distributions of cells in different phases of the cell cycle
were not significantly different (Table
I). We conclude that the observed
differences in pH3 levels are not simply because of a higher number of
cells in G2/M phase from one cell line.
To provide further evidence that elevated pH3 in Ciras-3 cells was not
a mitosis-related event, we studied the distribution of pH3 in Ciras-3
cells by indirect immunofluorescence. The distribution of pH3 in
Ciras-3 was similar to that of the TPA-stimulated 10T1/2 parental cells (compare Fig. 5 with Fig.
2). Most pH3 did not colocalize with regions of intense DAPI staining
in Ciras-3 nuclei, with the exception of nuclei in a minor population
of G2 phase cells. For the G2 phase cells, we
did observe pH3 associated with centromeric heterochromatin (see
arrows in Fig. 5A), in agreement with previous
results (17). These observations suggest that pH3 of most
ras-transformed mouse fibroblasts is associated with relaxed
chromatin regions.
Phosphorylated H3 Is Associated with Micrococcal Nuclease-sensitive
Chromatin in Ciras-3 Cells--
Nuclei isolated from Ciras-3 cells
were digested with micrococcal nuclease, and the chromatin fragments
were sequentially solubilized with buffers of increasing ionic
strength. As the ionic strength of the extracting buffer increased so
did the lengths of the chromatin fragments, in agreement with our
previous results (22) (Fig.
6A). Fractions SS 0.05, SS
0.10, and SS 0.20 accounted for approximately 30% of the chromatin,
with 70% of the chromatin being present in fractions SS 0.40 and the
residual nuclear pellet (P). Histones isolated from these
chromatin fractions were electrophoretically resolved on
SDS-polyacrylamide gels and transferred to nitrocellulose membranes,
which were stained with India ink (Fig. 6B). Fig.
6C shows that pH3 levels were higher in the chromatin
fractions SS 0.05, SS 0.10, and SS 0.20 than in fractions SS 0.40 and
P. This result provides evidence that the pH3 observed outside of
condensed chromatin regions (Fig. 5) is associated with less condensed
regions of chromatin in Ciras-3 cells.
Ras-transformed and Parental Mouse Fibroblasts Have Similar H3
Phosphatase Activities--
Increased phosphorylation of H3 in the
ras-transformed cells may be a consequence of increased H3
kinase activity and/or decreased H3 phosphatase activity. Histones
incubated with cellular extracts isolated from 10T1/2 and
Ciras-3 cells were electrophoretically resolved on SDS gels and then
transferred to nitrocellulose. Western blot analysis with anti-pH3
antibodies determined the amount of pH3 remaining following incubation
with the cellular extracts, providing a measure of the H3 phosphatase
activity. Fig. 7 shows that the H3
phosphatase activities were similar in the cellular extracts.
The activities of the two major protein phosphatases, PP1 and PP2A, in
mammalian cells can be distinguished by their sensitivity to okadaic
acid (30). PP2A activity is completely inhibited at 1 nM
okadaic acid, whereas 50% inhibition of PP1 activity is observed at
10-15 nM okadaic acid. A cellular extract from
10T1/2 cells was incubated with histones and 2 or 100 nM okadaic acid and incubated for various times. Fig.
8 shows that for control and 2 nM okadaic acid dephosphorylation of pH3, 29 and 39%,
respectively, of the pH3 remained after 60 min. However, when 100 nM okadaic acid was added to the cellular extract,
dephosphorylation of pH3 was not observed following 60 min of
incubation. These observations suggest that PP1 is the major H3
phosphatase.
The Level of pH3 Is Increased upon Induction of the ras Oncogene in
2H1 Cells--
To test if altered levels of pH3 are an early event in
cellular transformation, which occurs upon expression of oncogenic ras, we used the mouse fibroblast cell line, 2H1, which is a
10T1/2 cell line transfected with an inducible-ras
oncogene (21). In these cells, ras oncogene expression is
controlled by a metallothionein promoter, which can be induced by
treating the cells with 100 µM ZnSO4. Fig.
9 shows the levels of Ras and pH3 at
different times after the induction of the ras oncogene. One
h after the addition of zinc, Ras levels were increased severalfold,
diminishing over 18 h. The amount of pH3 increased rapidly for
2 h and then increased at a much slower rate. These observations
show the rapidity and sustained phosphorylation of H3 in response to
the expression of the oncoprotein Ras. Treatment of parental
10T1/2 cells with 100 µM ZnSO4 for 0, 8, or 24 h did not result in increased levels of phosphorylated
H3, and therefore phosphorylation of H3 was not affected by
ZnSO4 treatment alone (data not shown).
Phosphorylation of H3 in Cell Lines Transformed with Oncogenes
Encoding Protein Kinases--
Previously we reported that mouse
fibroblasts transformed with oncogenes (e.g. fes,
mos, c-myc) whose products stimulate the Ras-MAPK
signaling pathway have elevated levels of phosphorylated H1 (9, 11, 31,
32). The relative level of pH3 in the control NIH-3T3 cells was
compared with the pH3 level in the oncogene-transformed cells. There
was an increase in the level of pH3 in the fes-, mos-, and myc-transformed cells in comparison
with the NIH-3T3 parental cells (Fig.
10). Table I shows that the cell cycle
distributions of parental and oncogene-transformed NIH-3T3 mouse
fibroblasts were closely matched. These results show that cells
transformed with various different oncogenes have increased levels
of pH3.
In this study, we show that activation of Ras-MAPK pathway in
quiescent murine fibroblasts treated with phorbol esters or growth
factors results in the phosphorylation of Ser-10 of H3. We demonstrate
that pH3 is located with chromatin that is not highly condensed, and we
provide direct evidence that pH3 is associated with the induced
c-fos and c-myc genes.
The c-fos gene is transcribed in quiescent cells; however,
elongation of the gene is blocked approximately 100 nucleotides from
the site of initiation (33). Stimulation of the Ras-MAPK pathway
results in the release of this block in elongation. It is possible that
phosphorylation of H3 associated with the c-fos gene allows
the chromatin fiber to be less compact, favouring elongation.
Consistent with this hypothesis, the c-fos chromatin becomes
more DNase I sensitive following activation of the Ras-MAPK pathway
(34). Similarly, phosphorylation of H3 may release the block within the
c-myc gene (35). Increased c-myc expression is
seen later than that of c-fos (29, 36), concurrent with the
induced expression of these genes is the appearance of unfolded nucleosomes along the coding region of the c-fos and
c-myc genes (29). Dynamically acetylated H3 is the target of
mitogen-stimulated phosphorylation (18). As the H3 tail contributes to
the folding and inter-association of chromatin fibers, modification of
the H3 tail by acetylation and phosphorylation may destabilize higher order compaction of the chromatin fiber and contribute to maintaining the unfolded structure of the transcribing nucleosome (2, 6, 37-41).
Although the H3 that is the target of mitogen-stimulated
phosphorylation is dynamically acetylated, it should be noted that acetylation does not predispose H3 to phosphorylation (18). Further,
the anti-pH3 antibody will not bind to hyperacetylated H3 unless it is
phosphorylated (42). In stimulated mouse fibroblasts, most newly
phosphorylated H3 is non-, mono-, and diacetylated (18).
Murine fibroblasts transformed with ras have elevated levels
of Ser-10 pH3. Increased levels of pH3 are seen soon after Ras expression is elevated. Either an increased H3 kinase and/or decreased H3 phosphatase activity would result in an elevated level of pH3. The
activity of PP1, which our studies indicate is the H3 phosphatase, is
regulated by cyclin-dependent kinases (cdc2/cyclin A;
cdc2/cyclin B) (43). Increased activity of these kinases in the
ras-transformed cells may decrease the activity of PP1.
However, we found that the activities of H3 phosphatase in parental and
ras-transformed mouse fibroblasts were similar. We conclude
that the increased levels of pH3 in the ras-transformed
cells are due to increased activity of the H3 kinase.
An increased level of pH3 is also observed in cells transformed with
fes, mos, and myc oncogenes. Several of these
oncogenes code for serine/threonine or tyrosine kinases that act upon
the Ras-MAPK signaling pathway (31). Mammalian cells transformed with
c-myc have a stimulated Ras-MAPK pathway (11). Further, we
found that the MAPK (ERK-1 and -2) activity was higher in cellular extracts from the ras-, fes-, mos-,
and myc-oncogene transformed cells than in the parental
cellular extracts (data not shown). By persistent activation of the
Ras-MAPK signaling pathway, the phosphorylated isoforms of H3 would
remain elevated, resulting in the destabilization of chromatin observed
in oncogene-transformed cells (8, 9, 44). Consistent with this idea is
the observation that pH3 of ras-transformed cells is
associated with less condensed chromatin regions. The increased steady
state levels of pH3 may result in deregulation of transcription at the
level of transcriptional elongation, resulting in aberrant gene
expression observed in cancer cells (45-47).
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-minimal essential medium plus 10% fetal
bovine serum (Intergen, Purchase, NY). Cells were plated in 15 ml of
the above medium at 5 × 105 cells per 150-mm diameter
plastic tissue culture dish and grown for 72 h. The proportion
of cells in the different cell cycle phases was determined by
flow cytometry (9).
80 °C.
-glycerophosphate). For some experiments, the protein
phosphatase inhibitors were omitted; we did not observe changes in the
relative levels of pH3 in samples isolated with and without these
inhibitors. Nuclei were recovered by centrifugation at 1500 × g for 10 min. All centrifugations were carried out at
4 °C. Nuclei were resuspended in 3 ml of RSB buffer (10 mM Tris-HCl, pH 7.6, 3 mM MgCl2, 10 mM NaCl, 1 mM PMSF, and protein phosphatase
inhibitors). Nuclei were extracted with 0.4 N
H2SO4 to isolate total histones. The samples
were precipitated with trichloroacetic acid and then resuspended in
double distilled H2O.
-glycerophosphate, 10 mM sodium fluoride,
and 1 mM sodium orthovanadate) that had an increasing
concentration of sodium chloride (0.05, 0.1, 0.2, and 0.4 M). The supernatants SS0.05, SS0.10, SS0.20, and SS0.40
were collected following centrifugation. The residual nuclear material
(P) remaining after the final extraction was saved. Proteins and DNA
fragments were isolated and resolved on SDS-15% polyacrylamide gels
and 1% agarose gels, respectively, as described previously (22,
23).
matrix
attachment region (IG
MAR), c-fos, c-myc, and
prolactin. All clones are mouse genomic sequences except for the
prolactin clone, which has a mouse cDNA insert. For IG
MAR, a
2.85-kb BamHI-HindIII fragment from the
recombinant plasmid pG19/45 was isolated (25). A 2.6-kb BglI
fragment from the recombinant pSVfos plasmid carrying mouse genomic
c-fos was isolated (26). A 2.1-kb PvuII fragment from the mouse genomic c-myc DNA sequence containing a
segments of exon 2 and extending into exon 3 was isolated (27). A
0.8-kb mouse prolactin cDNA insert which is subcloned into the Gem
2 plasmid was isolated (28).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (20K):
[in a new window]
Fig. 1.
Effect of EGF and TPA treatment on H3
phosphorylation in quiescent 10T1/2 mouse fibroblasts.
Total histone was extracted from 10T1/2 cells that were serum
starved and then untreated (lane 1) or treated with 50 ng/ml
EGF for 5 min (lane 2), 50 ng/ml EGF for 30 min (lane
3), 100 nM TPA for 5 min (lane 4), or 100 nM TPA for 30 min (lane 5). The histone sample
(10 µg) was electrophoretically resolved on a 12.5%
SDS-polyacrylamide gel, transferred to membranes, and immunochemically
stained with anti-pH3. Panel A shows a Coomassie
Blue-stained gel. Panel B shows the immunochemically stained
membrane.

View larger version (30K):
[in a new window]
Fig. 2.
Localization of pH3 in nuclei of TPA-induced
10T1/2 mouse fibroblasts. Cells were co-stained with
anti-pH3 and DAPI. Digital optical sections of 0.3 mm were obtained and
false colored red (phosphorylated H3, panel A)
and blue (DAPI, panel C), and a composite image
was produced using Adobe Photoshop (panel B). The
arrows indicate regions of centromeric heterochromatin. The
bar represents 10 µm.
MAR DNA and prolactin DNA) did not
hybridize to the DNA bound to pH3. As expected, the CHIP assay with
chromatin from serum-starved cells, which had low levels of pH3, failed
to show an association of pH3 with any of these DNA sequences. These
observations provide direct evidence that pH3 of TPA-treated cells is
associated with the induced c-myc and c-fos
genes.

View larger version (75K):
[in a new window]
Fig. 3.
Association of pH3 with mitogen-induced
c-fos and c-myc genes. Quiescent
10T1/2 cells were stimulated with TPA (100 nM) for
30 min or unstimulated. DNA fragments associated with pH3 were isolated
by immunoprecipitation with anti-pH3, labeled with DIG, and hybridized
to a slot blot containing 0.5-µg DNA inserts of the c-myc,
c-fos, prolactin, and IG
MAR (IGK) genes
(lanes 3 and 4). In lanes 1 and
2, the blot was hybridized with labeled DNA isolated from
the total chromatin sample prior to immunoprecipitation (input
fraction).

View larger version (23K):
[in a new window]
Fig. 4.
Phosphorylated H3 of parental and
ras-transformed mouse fibroblasts. Total histone
was extracted from parental 10T1/2 cells (lane 1) and
Ciras-3 cells (lane 2). The total histone sample (10 µg)
was electrophoretically resolved on a 12.5% SDS-polyacrylamide gel,
transferred to membranes, and immunochemically stained with anti-pH3.
Panel A shows a Coomassie Blue-stained gel. Panel
B shows the immunochemically stained membrane.
Cell cycle distribution of parental and oncogene-transformed mouse
fibroblasts

View larger version (19K):
[in a new window]
Fig. 5.
Relative organization of pH3 and condensed
chromatin in ras-transformed Ciras-3 mouse
fibroblasts. Cells were co-stained with anti-pH3 and DAPI. Digital
optical sections of 0.3 mm were obtained and false colored
red (phosphorylated H3, panel A) and
blue (DAPI, panel C), and a composite image was
produced using Adobe Photoshop (panel B). The
arrows indicate regions of centromeric heterochromatin in a
G2 phase cell. The bar represents 10 µm.

View larger version (49K):
[in a new window]
Fig. 6.
Fractionation of Ciras-3 chromatin.
Ciras-3 chromatin was fractionated as described under "Materials and
Methods," yielding chromatin fractions SS 0.05 (15%), SS 0.10 (7%),
SS 0.20 (9%), SS0.40 (22%), and residual nuclear material P (47%).
The values given in the parentheses indicate the percentage of
chromatin in that fraction. DNA fragments (5 µg) isolated from these
fractions were electrophoretically resolved in 1% agarose gels, which
were stained with ethidium bromide (panel A). Lane
M contains HindIII-digested lambda DNA fragments.
Histones (5 µg) isolated from the chromatin fractions were resolved
on 15% SDS-polyacrylamide gels and transferred to nitrocellulose
membranes, which were stained with India ink (panel B). The
membrane was immunochemically stained with anti-pH3 (panel
C).

View larger version (18K):
[in a new window]
Fig. 7.
Comparison of H3 dephosphorylation in lysates
from parental and ras-transformed cells. Twenty
µg of cellular-extracted protein from 10T1/2 (2.9 × 104 cell equivalents) or Ciras-3 (3.5 × 104 cell equivalents) were incubated with 5 µg of total
histone substrate for 0, 15, 30, 45, and 60 min at 37 °C. The
reaction was stopped, and the proteins were separated by
SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose
membranes, and immunochemically stained with anti-pH3. The percent of
pH3 remaining after each time period was determined by densitometric
analysis of the Western blots as described under "Experimental
Procedures." Inspection of the India ink-stained immunoblot
showed that the protein loads in each lane were equivalent and that
protein degradation was not occurring (not shown).

View larger version (48K):
[in a new window]
Fig. 8.
Inhibition of H3 dephosphorylation by okadaic
acid in 10T1/2 cell extracts. Cell extracts were incubated
in the presence of 0, 2, or 100 nM okadaic acid and 5 µg
of total histone as substrate. The reaction mixture was incubated for
0, 30, or 60 min at 37 °C. The reaction was stopped, and the
proteins were separated on an SDS-polyacrylamide gel, transferred to
membranes, and immunochemically stained with anti-pH3. The percent of
pH3 remaining after each time period was determined by densitometric
analysis of the Western blots as described under "Experimental
Procedures."

View larger version (15K):
[in a new window]
Fig. 9.
Effect of induction of the
ras-oncogene on pH3 levels. Total histone was
extracted from 2H1 cells that were treated with 100 µM
ZnSO4 for 0, 1, 2, 4, 8, or 16 h. The relative levels
of pH3 and Ras from each sample were determined by densitometric
analysis of Western blots with anti-pH3 as described under
"Experimental Procedures."

View larger version (41K):
[in a new window]
Fig. 10.
Phosphorylated H3 of parental and
oncogene-transformed mouse fibroblasts. Total histone was isolated
from parental NIH-3T3 (lane 1) and NIH-3T3 cells transformed
with v-fes (lane 2), v-mos (lane
3), and c-myc (lane 4). The total histone
sample (10 µg) was electrophoretically resolved on a 12.5%
SDS-polyacrylamide gel, transferred to membranes, and immunochemically
stained with anti-pH3. Panel A shows a Coomassie
Blue-stained gel. Panel B shows the immunochemically stained
membrane.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
FOOTNOTES |
|---|
* This work was supported by the Cancer Research Society, Inc. (to J. A. W., J .R. D., and D. P. B.-J.), by a Medical Research Council operating grant (to D. P. B.-J.), and by Public Health Service Grant GM 40922 from the National Institutes of Health (to C. D. A.). The awards of a Manitoba Health Research Council Studentship (to D. N. C.), a Medical Research Council of Canada Senior Scientist (to J. R. D.), and a National Cancer Institute of Canada Terry Fox Senior Scientist (to J. A. W.) are also gratefully acknowledged.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by a Postdoctoral Fellowship from the Medical
Research Council of Canada and the Alberta Heritage Foundation for Medical Research.

To whom correspondence should be addressed: Dept. of
Biochemistry and Molecular Biology, Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada R3E 0W3. Tel.: 204-787-2391; Fax: 204-787-2190; E-mail: Davie@cc.umanitoba.ca.
2 M. J. Hendzel, unpublished observations.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
MAPK, mitogen-activated protein kinase;
pH3, phosphorylated H3;
EGF, epidermal growth factor;
TPA, 12-O-tetradecanoylphorbol
13-acetate;
PMSF, phenylmethylsulfonyl fluoride;
IG
MAR, immunoglobulin
matrix attachment region;
kb, kilobase;
DAPI, diamidinophenolindole.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
van Holde, K.,
and Zlatanova, J.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10548-10555 |
| 2. | Moore, S. C., and Ausio, J. (1997) Biochem. Biophys. Res. Commun. 230, 136-139[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Hansen, J. C. (1997) Chemtracts: Biochem. Mol. Biol. 10, 56-69 |
| 4. | Tse, C., and Hansen, J. C. (1997) Biochemistry 36, 11381-11388[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Leuba, S. H.,
Bustamante, C.,
Zlatanova, J.,
and van Holde, K.
(1998)
Biophys. J.
74,
2823-2829 |
| 6. |
Tse, C.,
Sera, T.,
Wolffe, A. P.,
and Hansen, J. C.
(1998)
Mol. Cell. Biol.
18,
4629-4638 |
| 7. | Holth, L. T., Chadee, D. N., Spencer, V. A., Samuel, S. K., Safneck, J. R., and Davie, J. R. (1998) Int. J. Oncol. 13, 827-837 [Medline] [Order article via Infotrieve] |
| 8. |
Laitinen, J.,
Sistonen, L.,
Alitalo, K.,
and Holtta, E.
(1990)
J. Cell Biol.
111,
9-17 |
| 9. |
Chadee, D. N.,
Taylor, W. R.,
Hurta, R. A.,
Allis, C. D.,
Wright, J. A.,
and Davie, J. R.
(1995)
J. Biol. Chem.
270,
20098-20105 |
| 10. |
Herrera, R. E.,
Chen, F.,
and Weinberg, R. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
11510-11515 |
| 11. | Amundadottir, L. T., and Leder, P. (1998) Oncogene 16, 737-746[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Mahadevan, L. C., Willis, A. C., and Barratt, M. J. (1991) Cell 65, 775-783[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Cano, E., Hazzalin, C. A., Kardalinou, E., Buckle, R. S., and Mahadevan, L. C. (1995) J. Cell Sci. 108, 3599-3609[Abstract] |
| 14. |
Ebinu, J. O.,
Bottorff, D. A.,
Chan, E. Y.,
Stang, S. L.,
Dunn, R. J.,
and Stone, J. C.
(1998)
Science
280,
1082-1086 |
| 15. |
Taylor, S. S.
(1982)
J. Biol. Chem.
257,
6056-6063 |
| 16. | Shibata, K., Inagaki, M., and Ajiro, K. (1990) Eur. J. Biochem. 192, 87-93[Medline] [Order article via Infotrieve] |
| 17. | Hendzel, M. J., Wei, Y., Mancini, M. A., Van Hooser, A., Ranalli, T., Brinkley, B. R., Bazett-Jones, D. P., and Allis, C. D. (1997) Chromosoma 106, 348-360[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Barratt, M. J.,
Hazzalin, C. A.,
Cano, E.,
and Mahadevan, L. C.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
4781-4785 |
| 19. |
Egan, S. E.,
McClarity, G. A.,
Jarolim, L.,
Wright, J. A.,
Spiro, I.,
Hager, G.,
and Greenberg, A. H.
(1987)
Mol. Cell. Biol.
7,
830-837 |
| 20. |
Egan, S. E.,
Wright, J. A.,
Jarolim, L.,
Yanagihara, K.,
Bassin, R. H.,
and Greenberg, A. H.
(1987)
Science
238,
202-205 |
| 21. | Haliotis, T., Trimble, W., Chow, S., Bull, S., Mills, G., Girard, P., Kuo, J. F., and Hozumi, N. (1990) Int. J. Cancer 45, 1177-1183[Medline] [Order article via Infotrieve] |
| 22. |
Rocha, E.,
Davie, J. R.,
Van Holde, K. E.,
and Weintraub, H.
(1984)
J. Biol. Chem.
259,
8558-8563 |
| 23. | Delcuve, G. P., and Davie, J. R. (1989) Biochem. J. 263, 179-186[Medline] [Order article via Infotrieve] |
| 24. |
Hendzel, M. J.,
Kruhlak, M. J.,
and Bazett-Jones, D. P.
(1998)
Mol. Biol. Cell
9,
2491-2507 |
| 25. | Cockerill, P. N., and Garrard, W. T. (1986) Cell 44, 273-282[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Schonthal, A., Herrlich, P., Rahmsdorf, H. J., and Ponta, H. (1988) Cell 54, 325-334[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Bernard, O., Cory, S., Gerondakis, S., Webb, E., and Adams, J. M. (1983) EMBO J. 2, 2375-2383[Medline] [Order article via Infotrieve] |
| 28. | Colosi, P., Talamantes, F., and Linzer, D. I. (1987) Mol. Endocrinol. 1, 767-776[Abstract] |
| 29. |
Chen, T. A.,
and Allfrey, V. G.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
5252-5256 |
| 30. | Paulson, J. R., Patzlaff, J. S., and Vallis, A. J. (1996) J. Cell Sci. 109, 1437-1447[Abstract] |
| 31. | Fanger, G. R., Gerwins, P., Widmann, C., Jarpe, M. B., and Johnson, G. L. (1997) Curr. Opin. Genet. Dev. 7, 67-74[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Katz, M. E., and McCormick, F. (1997) Curr. Opin. Genet. Dev. 7, 75-79[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Pinaud, S., and Mirkovitch, J. (1998) J. Mol. Biol. 280, 785-798[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Feng, J., and Villeponteau, B. (1992) Biochim. Biophys. Acta 1130, 253-258[Medline] [Order article via Infotrieve] |
| 35. |
Krumm, A.,
Meulia, T.,
Brunvand, M.,
and Groudine, M.
(1992)
Genes Dev.
6,
2201-2213 |
| 36. | Greenberg, M. E., and Ziff, E. B. (1984) Nature 311, 433-438[CrossRef][Medline] [Order article via Infotrieve] |
| 37. |
Ridsdale, J. A.,
Hendzel, M. J.,
Delcuve, G. P.,
and Davie, J. R.
(1990)
J. Biol. Chem.
265,
5150-5156 |
| 38. | Nightingale, K. P., Wellinger, R. E., Sogo, J. M., and Becker, P. B. (1998) EMBO J. 17, 2865-2876[CrossRef][Medline] [Order article via Infotrieve] |
| 39. |
Krajewski, W. A.,
and Becker, P. B.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
1540-1545 |
| 40. |
Madisen, L.,
Krumm, A.,
Hebbes, T. R.,
and Groudine, M.
(1998)
Mol. Cell. Biol.
18,
6281-6292 |
| 41. |
Walia, H.,
Chen, H. Y.,
Sun, J.-M.,
Holth, L. T.,
and Davie, J. R.
(1998)
J. Biol. Chem.
273,
14516-14522 |
| 42. |
Espinos, E.,
le Van Thai, A.,
Pomies, C.,
and Weber, M. J.
(1999)
Mol. Cell. Biol.
19,
3474-3484 |
| 43. |
Dohadwala, M.,
Da Cruz, E,
Silva, E. F.,
Hall, F. L.,
Williams, R. T.,
Carbonaro-Hall, D. A.,
Nairn, A. C.,
Greengard, P.,
and Berndt, N.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
6408-6412 |
| 44. | Smith, M. L., Bortnick, R. A., Sheikh, M. S., and Fornace, A. J. J. (1998) Exp. Cell Res. 242, 235-243[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Lengyel, E., Wang, H., Gum, R., Simon, C., Wang, Y., and Boyd, D. (1997) Oncogene 14, 2563-2573[CrossRef][Medline] [Order article via Infotrieve] |
| 46. |
Patton, S. E.,
Martin, M. L.,
Nelsen, L. L.,
Fang, X.,
Mills, G. B.,
Bast, R. C., Jr.,
and Ostrowski, M. C.
(1998)
Cancer Res.
58,
2253-2259 |
| 47. |
Shilatifard, A.
(1998)
FASEB J.
12,
1437-1446 |
This article has been cited by other articles:
![]() |
D. Titolo, C. M. Mayer, S. S. Dhillon, F. Cai, and D. D. Belsham Estrogen Facilitates both Phosphatidylinositol 3-Kinase/Akt and ERK1/2 Mitogen-Activated Protein Kinase Membrane Signaling Required for Long-Term Neuropeptide Y Transcriptional Regulation in Clonal, Immortalized Neurons J. Neurosci., June 18, 2008; 28(25): 6473 - 6482. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ke, Q. Li, T. P. Ellen, H. Sun, and M. Costa Nickel compounds induce phosphorylation of histone H3 at serine 10 by activating JNK-MAPK pathway Carcinogenesis, June 1, 2008; 29(6): 1276 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-G. Kim, K. W. Lee, Y.-Y. Cho, N. J. Kang, S.-M. Oh, A. M. Bode, and Z. Dong Mitogen- and Stress-Activated Kinase 1-Mediated Histone H3 Phosphorylation Is Crucial for Cell Transformation Cancer Res., April 1, 2008; 68(7): 2538 - 2547. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Mellstrom, M. Savignac, R. Gomez-Villafuertes, and J. R. Naranjo Ca2+-Operated Transcriptional Networks: Molecular Mechanisms and In Vivo Models Physiol Rev, April 1, 2008; 88(2): 421 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Choi, B. S. Kang, J.-H. Shim, Y.-Y. Cho, B. Y. Choi, A. M. Bode, and Z. Dong Cot, a novel kinase of histone H3, induces cellular transformation through up-regulation of c-fos transcriptional activity FASEB J, January 1, 2008; 22(1): 113 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Villegas, V. Burzio, C. Villota, E. Landerer, R. Martinez, M. Santander, R. Martinez, R. Pinto, M. I. Vera, E. Boccardo, et al. Expression of a novel non-coding mitochondrial RNA in human proliferating cells Nucleic Acids Res., December 18, 2007; 35(21): 7336 - 7347. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Jamaluddin, I. Chen, F. Yang, X. Jiang, M. Jan, X. Liu, A. I. Schafer, W. Durante, X. Yang, and H. Wang Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin Agene Blood, November 15, 2007; 110(10): 3648 - 3655. [Abstract] [Full Text] [PDF] |
||||
![]() |